References
Andersen, L.B., Ballester, R., Marchuk, D.A., Chang, E., Gutmann, D.H., Saulino, A.M., Camonis, J., Wigler, M. & Collins, F.S. (1993) A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Molecular and Cellular Biology 13, 487-95.
Basu, T.N., Gutmann, D.H., Fletcher, J.A., Glover, T.W., Collins, F.S. & Downward, J. (1992) Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356, 713-15.
Bollag, G. & McCormick, F. (1992) Ras regulation.NF is enough of GAP. Nature 356, 663-4.
Brannan, C.I., Perkins, A.S., Vogel, K.S., Ratner, N., Nordlund, M.L., Reid, S.W., Buchberg, A.M., Jenkins, N.A., Parada, L.F. & Copeland, N.G. (1994) Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes and Development 8, 1019-29.
Cawthon, R.M., Weiss, R., Xu, G.F., Viskochil, D., Culver, M., Stevens, J., Robertson, M., Dunn, D., Gesteland, R., O'Connell, P. & White, R. (1990) A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 62, 193-201.
Chirgwin, J.M., Przybyla, A.E., Macdonald, R.J. & Rutter, W.J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.Biochemistry 18, 5294-9.
Chomczynski, P. & Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162, 156-9.
Danglot, G., Regnier, V., Fauvet, D., Vassal, G., Kujas, M. & Bernheim, A. (1995) Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5' part of the gene.Human Molecular Genetics 4, 915-20.
Daston, M.M. & Ratner, N. (1992) Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development.Developmental Dynamics 195, 216-26.
Daston, M.M., Scrable, H., Nordlund, M., Sturbaum, A.K., Nissen, L.M. & Ratner, N. (1992) The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes. Neuron 8, 415-28.
DeClue, J.E., Papageorge, A.G., Fletcher, J.A., Diehl, S.R., Ratner, N., Vass, W.C. & Lowy, D. (1992) Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69, 265-73.
Gesteland, R., O'Connell, P. & White, R. (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62, 193-201.
Golubic, M., Roudebush, M., Dobrowolski, S., Wolfman, A. & Stacey, D.W. (1992) Catalytic properties, tissue and intracellular distribution of neurofibromin. Oncogene 7, 2151-9.
Griesser, J., Kaufmann, D., Maier, B., Mailhammer, R., Kuehl, P. & Krone, W. (1997) Post-transcriptional regulation of neurofibromin level in cultured human melanocytes in response to growth factors.Journal of Investigative Dermatology 108, 275-80.
Gutmann, D.H. (1994) New insights into the neurofibromatoses.Current Opinion in Neurology 7, 166-71.
Gutmann, D.H., Geist, R.T., Wright, D.E. & Snider, W.D. (1995) Expression of the neurofibromatosis 1 (NF1) isoforms in developing and adult rat tissues. Cell Growth and Differentiation 6, 315-23.
Gutmann, D., Tennekoon, G., Cole, J., Collins, F. & Rutkowski, J. (1993) Modulation of the neurofibromatosis type 1 gene product, neurofibromin, during Schwann cell differentiation. Journal of Neuroscience Research 36, 216-23.
Gutmann, D., Wood, D. & Collins, F. (1991) Identification of the neurofibromatosis type 1 gene product.Proceedings of the National Academy of Sciences (USA) 88, 9658-62.
Hermonen, J., Hirvonen, O., YlÄ-Outinen, H., Lakkakorpi, J., Bjorkstrand, A.-S., Laurikainen, L., Kallioinen, M., Oikarinen, A., Peltonen, S. & Peltonen, J. (1995) Neurofibromin: expression by normal human keratinocytes in vivo and in vitro and in epidermal malignancies.Laboratory Investigation 73, 221-8.
Hirvonen, O., Peltonen, S., Hirvonen, H., BjÖrkstrand, A.-S. & Peltonen, J. (1996) Expression of laminin and collagen genes by cells cultured from developing human sciatic nerves. Journal of Peripheral Nervous System 1, 42-52.
Huson, S. (1994) Neurofibromatosis 1: a clinical overview.In: The Neurofibromatoses, A Pathogenetic and Clinical Overview (edited by Huson, S. & Hughes, R.), pp 160-203. London: Chapman & Hall.
Huynh, D.P., Nechiporuk, T. & Pulst, S.M. (1994) Differential expression and tissue distribution of type I and type II neurofibromins during mouse fetal development. Developmental Biology 161, 538-51.
Jaakkola, S., Savunen, O., Halme, T., Uitto, J. & Peltonen, J. (1993) Basement membranes during development of human nerve: Schwann cells and perineurial cells display marked changes in their expression profiles for laminin subunits and β1 and β4 integrins.Journal of Neurocytology 22, 215-30.
Jacks, T., Shih, T.S., Schmitt, E.M., Bronson, R.T., Bernards, A. & Weinberg, R.A. (1994) Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nature Genetics 7, 353-61.
Legius, E., Marchuk, D.A., Collins, F.S. & Glover, T.W. (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nature Genetics 3, 122-6.
Leivo, I. & Engvall, E. (1988) Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development. Proceedings of the National Academy of Sciences (USA) 85, 1544-8.
Morcos, P., Thapar, N., Tusneem, N., Stacey, D. & Tamanoi, F. (1996) Identification of neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles. Molecular and Cellular Biology 16, 2496-503.
Muona, P., Jaakkola, S., Salonen, V. & Peltonen, J. (1993) Expression of glucose transporter 1 in adult and developing human peripheral nerve. Diabetologia 36, 133-40.
Nishi, T., Lee, P.S., Oka, K., Levin, V.A., Tanase, S., Morino, Y. & Saya, H. (1991) Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation. Oncogene 6, 1555-9.
Ochoa, J. (1971) The sural nerve of the human foetus: electron microscope observations and counts of axons.Journal of Anatomy 108, 231-45.
Peltonen, J., Jaakkola, S., Lebwohl, M., Renvall, S., Risteli, L., Virtanen, I. & Uitto, J. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. (1988) Laboratory Investigation 59, 760-71.
Peltonen, J., Jaakkola, S. & Uitto, J. (1991) In situ hybridization and immunodetection techniques for simultaneous localization of messenger RNAs and protein epitopes in tissue sections and cultured cells. Methods of Enzymology 203, 476-84.
Riccardi, V. (1981) von Recklinghausen neurofibromatosis.New England Journal of Medicine 305, 1617-27.
Rosenbaum, T., Boissy, Y.L., Kombrinck, K., Brannan, C.I., Jenkins, N.A., Copeland, N.G. & Ratner, N. (1995) Neurofibromin-deficient fibroblasts fail to form perineurium in vitro. Development 121, 3583-92.
Sawada, S., Florell, S., Purandare, S.M., Ota, M., Stephens, K. & Viskochil, D. (1996) Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nature Genetics 14, 110-2.
Serra, E., Puig, S., Otero, D., Gaona, A., Kruyer, H., Ars, E., Estivill, X. & Lazaro, C. (1997) Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. American Journal of Human Genetics 61, 512-9.
Suzuki, H., Takahashi, K., Kubota, Y. & Shibahara, S. (1992) Molecular cloning of a cDNA coding for neurofibromatosis type 1 protein isoform lacking the domain related to ras GTPase-activating protein.Biochemical and Biophysical Research Communications 187, 984-90.
Teinturier, C., Danglot, G., Slim, R., Pruliere, D., Launay, J. & Bernheim, A. (1992) The neurofibromatosis 1 gene transcripts expressed in peripheral nerve and neurofibromas bear the additional exon located in the GAP domain. Biochemical and Biophysical Research Communications 2, 851-7.
von Deimling, A. & Krone, W. (1997) Neurofibromatosis type 1. In: Tumours of the Nervous System (edited by Kleihues, P. & Cavenee, W.K.), pp 172-74.Lyon: International Agency for Research on Cancer.
Wallace, M., Marchuk, D., Andersen, L., Letcher, R., Odeh, H., Saulino, A., Fountain, J., Brereton, A., Nicholson, J., Mitchell, A., Brownstein, B. & Collins, F. (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249, 181-6.
Weinberg, R.A. (1991) Tumor suppressor genes. Science 254, 1138-46.
Wrabetz, L., Feltri, M.L., Kim, H., Daston, M., Kamholz, J., Scherer, S.S. & Ratner, N. (1995) Regulation of neurofibromin expression in rat sciatic nerve and cultured Schwann cells. Glia 15, 22-32.
Xu, G., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R. & Weiss, R. (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62, 599-608.
YlÄ-Outinen, H., Aaltonen, V., BjÖrkstrand, A.-S., Hirvonen, O., Lakkakorpi, J., VÄhÄ-Kreula, M., Laato, M. & Peltonen, J. (1998) Upregulation of tumor suppressor protein neurofibromin in normal wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor-β1 (TGF-β1) elicited increase in neurofibromin mRNA steady-state levels in dermal fibroblasts. Journal of Investigative Dermatology 110, 232-7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hirvonen, O., Lakkakorpi, J., Aaltonen, V. et al. Developmental regulation of NF1 tumor suppressor gene in human peripheral nerve. J Neurocytol 27, 939–951 (1998). https://doi.org/10.1023/A:1006905224474
Issue Date:
DOI: https://doi.org/10.1023/A:1006905224474